Bisphosphonate-associated osteonecrosis of the jaws

a therapeutic dilemma

Rossi Diego, Ornella D'Orto, Davide Pagani, Alessandro Agazzi, Umberto Marzano, Giancarlo Derada Troletti, Walter Fontanella, Lorenzo Pignataro

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: To describe our experience in prevention and treatment of mandibular and maxillary osteonecrosis, an emerging complication of long-term intravenous administration of bisphosphonates. Study design: Between February 2004 and February 2006, 10 patients who had received zoledronic acid intravenously because of multiple bone myelomas or bone metastases were treated for mandibular and maxillary osteonecrosis in the Departments of Otorhinolaryngology and Maxillofacial Surgery of our institution. Results: All of the patients underwent surgical sequestrectomies. More extensive surgery was necessary in 3 cases. There were no major complications, and the majority of the patients are alive with no signs of infection or bone exposure. Conclusions: Our experience confirms that bisphosphonate therapy contributes to the pathogenesis of mandibular and maxillary osteonecrosis. Surgery seems to be necessary in the majority of the patients, although the most adequate procedure is far from being standardized and prevention seems to play a pivotal role.

Original languageEnglish
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Volume103
Issue number3
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Osteonecrosis
zoledronic acid
Diphosphonates
Bone and Bones
Oral Surgery
Otolaryngology
Therapeutics
Multiple Myeloma
Intravenous Administration
Neoplasm Metastasis
Infection

ASJC Scopus subject areas

  • Dentistry(all)
  • Pathology and Forensic Medicine
  • Radiology Nuclear Medicine and imaging
  • Surgery

Cite this

Bisphosphonate-associated osteonecrosis of the jaws : a therapeutic dilemma. / Diego, Rossi; D'Orto, Ornella; Pagani, Davide; Agazzi, Alessandro; Marzano, Umberto; Derada Troletti, Giancarlo; Fontanella, Walter; Pignataro, Lorenzo.

In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, Vol. 103, No. 3, 03.2007.

Research output: Contribution to journalArticle

Diego, Rossi ; D'Orto, Ornella ; Pagani, Davide ; Agazzi, Alessandro ; Marzano, Umberto ; Derada Troletti, Giancarlo ; Fontanella, Walter ; Pignataro, Lorenzo. / Bisphosphonate-associated osteonecrosis of the jaws : a therapeutic dilemma. In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2007 ; Vol. 103, No. 3.
@article{b361c65496954d8b8b534eaa97392d72,
title = "Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma",
abstract = "Objective: To describe our experience in prevention and treatment of mandibular and maxillary osteonecrosis, an emerging complication of long-term intravenous administration of bisphosphonates. Study design: Between February 2004 and February 2006, 10 patients who had received zoledronic acid intravenously because of multiple bone myelomas or bone metastases were treated for mandibular and maxillary osteonecrosis in the Departments of Otorhinolaryngology and Maxillofacial Surgery of our institution. Results: All of the patients underwent surgical sequestrectomies. More extensive surgery was necessary in 3 cases. There were no major complications, and the majority of the patients are alive with no signs of infection or bone exposure. Conclusions: Our experience confirms that bisphosphonate therapy contributes to the pathogenesis of mandibular and maxillary osteonecrosis. Surgery seems to be necessary in the majority of the patients, although the most adequate procedure is far from being standardized and prevention seems to play a pivotal role.",
author = "Rossi Diego and Ornella D'Orto and Davide Pagani and Alessandro Agazzi and Umberto Marzano and {Derada Troletti}, Giancarlo and Walter Fontanella and Lorenzo Pignataro",
year = "2007",
month = "3",
doi = "10.1016/j.tripleo.2006.09.022",
language = "English",
volume = "103",
journal = "Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics",
issn = "1079-2104",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Bisphosphonate-associated osteonecrosis of the jaws

T2 - a therapeutic dilemma

AU - Diego, Rossi

AU - D'Orto, Ornella

AU - Pagani, Davide

AU - Agazzi, Alessandro

AU - Marzano, Umberto

AU - Derada Troletti, Giancarlo

AU - Fontanella, Walter

AU - Pignataro, Lorenzo

PY - 2007/3

Y1 - 2007/3

N2 - Objective: To describe our experience in prevention and treatment of mandibular and maxillary osteonecrosis, an emerging complication of long-term intravenous administration of bisphosphonates. Study design: Between February 2004 and February 2006, 10 patients who had received zoledronic acid intravenously because of multiple bone myelomas or bone metastases were treated for mandibular and maxillary osteonecrosis in the Departments of Otorhinolaryngology and Maxillofacial Surgery of our institution. Results: All of the patients underwent surgical sequestrectomies. More extensive surgery was necessary in 3 cases. There were no major complications, and the majority of the patients are alive with no signs of infection or bone exposure. Conclusions: Our experience confirms that bisphosphonate therapy contributes to the pathogenesis of mandibular and maxillary osteonecrosis. Surgery seems to be necessary in the majority of the patients, although the most adequate procedure is far from being standardized and prevention seems to play a pivotal role.

AB - Objective: To describe our experience in prevention and treatment of mandibular and maxillary osteonecrosis, an emerging complication of long-term intravenous administration of bisphosphonates. Study design: Between February 2004 and February 2006, 10 patients who had received zoledronic acid intravenously because of multiple bone myelomas or bone metastases were treated for mandibular and maxillary osteonecrosis in the Departments of Otorhinolaryngology and Maxillofacial Surgery of our institution. Results: All of the patients underwent surgical sequestrectomies. More extensive surgery was necessary in 3 cases. There were no major complications, and the majority of the patients are alive with no signs of infection or bone exposure. Conclusions: Our experience confirms that bisphosphonate therapy contributes to the pathogenesis of mandibular and maxillary osteonecrosis. Surgery seems to be necessary in the majority of the patients, although the most adequate procedure is far from being standardized and prevention seems to play a pivotal role.

UR - http://www.scopus.com/inward/record.url?scp=33847163527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847163527&partnerID=8YFLogxK

U2 - 10.1016/j.tripleo.2006.09.022

DO - 10.1016/j.tripleo.2006.09.022

M3 - Article

VL - 103

JO - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

JF - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

SN - 1079-2104

IS - 3

ER -